Clinical Trials Logo

Hypercalciuric Hypercalcemia clinical trials

View clinical trials related to Hypercalciuric Hypercalcemia.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03301038 Recruiting - Genetic Disease Clinical Trials

Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria

RICHH
Start date: July 25, 2018
Phase: Phase 2
Study type: Interventional

This study evaluates the efficacy of rifampin in the treatment of hypercalcemia and/or hypercalciuria in participants with at least one inactivating mutation of the CYP24A1 gene. Eligible subjects will receive rifampin for a total of 16 weeks during this study.